Company / Revenue per Share
OptimizeRx Corp Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.99
FY2025
5-year range
$2.85 / $4.99
FY2021-FY2025
Trend
+19.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has increased for 5 consecutive years, from $1.68 in FY2020 to $4.99 in FY2025.
Based on SEC 10-K filings.
4.99 in FY2025 with a 5-year CAGR of +24.3%.
Improved from $3.51 to $4.99 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +24.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's revenue per share has grown for 5 consecutive years.
- In FY2025, revenue per share increased 19.5% year-over-year.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.99 | +19.5% |
| FY2024 | $4.18 | +18.9% |
| FY2023 | $3.51 | +2.3% |
| FY2022 | $3.43 | +20.6% |
| FY2021 | $2.85 | +69.0% |
| FY2020 | $1.68 | -4.4% |
| FY2019 | $1.76 | +41.9% |
| FY2018 | $1.24 | +375.8% |
| FY2017 | $0.26 | +4.9% |
| FY2016 | $0.25 | -12.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026